Concepedia
Statistics
Publications
6
Citations
250
H-Index
Active since
1993
Affiliations
New Frontier(Current)
GlaxoSmithKline (United States)
GlaxoSmithKline (United Kingdom)
Rodd Polsky is an author at New Frontier specializing in pharmacology, immunology, and life sciences.
Publications per year
1993–2020
In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells.
Michael R. Mattern, G A Hofmann, Rodd Polsky et al. · PubMed · 1993 · 92 citations
Medicine, Cancer Biology, Pharmacology +17
Single ocular injection of a sustained-release anti -VEGF delivers 6 months pharmacokinetics and efficacy in a primate laser CNV model
Peter Adamson, Thomas Wilde, Eric Dobrzynski et al. · Journal of Controlled Release · 2016 · 59 citations · Full text
Pharmacy, Ophthalmology, Pharmaceutics +17
Immunomodulatory Effects of Anti-CD4 Antibody in Host Resistance against Infections and Tumors in Human CD4 Transgenic Mice
Danuta J. Herzyk, Elizabeth R. Gore, Rodd Polsky et al. · Infection and Immunity · 2001 · 47 citations
Life Sciences, Immunology, Pharmacology +17
Single-Organism Model of Host Defense against Infection: A Novel Immunotoxicologic Approach to Evaluate Immunomodulatory Drugs
Danuta J. Herzyk, Elizabeth V. Ruggieri, Lolita Cunningham et al. · Toxicologic Pathology · 1997 · 22 citations
Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates
Susan Laffan, Andrew S. Thomson, Shing Mai et al. · PLoS ONE · 2020 · 17 citations · Full text
1–5 of 6